Interstitial lung diseases
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients with interstitial lung disease s (ILDs) In patients with acute phase,treated o r untreated are eligible. In patients with chronic disease,untrea ted are eligible. 2. Participants must be fully informed abo ut the study and signed a written infor med consent.
Exclusion criteria
Exclusion criteria: 1. Cases not possible to cooperate with ex aminations such as pulmonary function t ests. 2. Cases with active respiratory infectio n. 3. Cases in which informed consent was obt ained for this study. 4. Cases judged by the attending physicia n to be an ineligible.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The differences in subsets and activation of T cells, B cells, macrophages, and granulocytes in bronchoalveolar lavage fluid and peripheral blood is compared with or without pulmonary fibrosis. Investigate the relationship between such deviation on cellular subsets and/or activation with later prognosis of ILD patients at 12 months. | — |
Countries
Japan
Contacts
Kochi Medical School, Kochi University Department of Respiratory Medicine and Allergology